Charles Swanton
Robert Charles Swanton is a British physician scientist specialising in oncology and cancer research. Swanton is a senior group leader at London's Francis Crick Institute, Royal Society Napier Professor in Cancer and thoracic medical oncologist at University College London and University College London Hospitals, co-director of the Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, and Chief Clinician of Cancer Research UK. Provided by Wikipedia
Showing 1 - 20 results of 30 for search 'Charles Swanton', query time: 0.06s
Refine Results
-
1
ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors. by Christopher Abbosh, Charles Swanton
Published 2021-10-01
Article -
2
-
3
APOBEC3 as a driver of genetic intratumor heterogeneity by Subramanian Venkatesan, Mihaela Angelova, Jirina Bartkova, Samuel F. Bakhoum, Jiri Bartek, Nnennaya Kanu, Charles Swanton
Published 2021-12-01
Article -
4
Cell-Free DNA–Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial by Richard D. Neal, Peter Johnson, Christina A. Clarke, Stephanie A. Hamilton, Nan Zhang, Harpal Kumar, Charles Swanton, Peter Sasieni
Published 2022-10-01
Article -
5
Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER status. by Qiyuan Li, Aron C Eklund, Nicolai Juul, Benjamin Haibe-Kains, Christopher T Workman, Andrea L Richardson, Zoltan Szallasi, Charles Swanton
Published 2010-12-01
Article -
6
RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma by Philip East, Gavin P. Kelly, Dhruva Biswas, Michela Marani, David C. Hancock, Todd Creasy, Kris Sachsenmeier, Charles Swanton, TRACERx consortium, Julian Downward, Sophie de Carné Trécesson
Published 2022-09-01
Article -
7
The CIN4 chromosomal instability qPCR classifier defines tumor aneuploidy and stratifies outcome in grade 2 breast cancer. by Attila Marcell Szász, Qiyuan Li, Aron C Eklund, Zsófia Sztupinszki, Andrew Rowan, Anna-Mária Tőkés, Borbála Székely, András Kiss, Miklós Szendrői, Balázs Győrffy, Zoltán Szállási, Charles Swanton, Janina Kulka
Published 2013-01-01
Article -
8
Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer by David R. Pearce, David R. Pearce, Ayse U. Akarca, Roel P. H. De Maeyer, Emily Kostina, Ariana Huebner, Ariana Huebner, Ariana Huebner, Monica Sivakumar, Monica Sivakumar, Takahiro Karasaki, Kavina Shah, Sam M. Janes, Nicholas McGranahan, Nicholas McGranahan, Venkat Reddy, Arne N. Akbar, David A. Moore, David A. Moore, Teresa Marafioti, Charles Swanton, Charles Swanton, Robert E. Hynds, Robert E. Hynds, Robert E. Hynds
Published 2023-06-01
Article -
9
Human endogenous retrovirus onco-exaptation counters cancer cell senescence through calbindin by Jan Attig, Judith Pape, Laura Doglio, Anastasiya Kazachenka, Eleonora Ottina, George R. Young, Katey S.S. Enfield, Iker Valle Aramburu, Kevin W. Ng, Nikhil Faulkner, William Bolland, Venizelos Papayannopoulos, Charles Swanton, George Kassiotis
Published 2023-07-01
Article -
10
Refphase: Multi-sample phasing reveals haplotype-specific copy number heterogeneity. by Thomas B K Watkins, Emma C Colliver, Matthew R Huska, Tom L Kaufmann, Emilia L Lim, Cody B Duncan, Kerstin Haase, Peter Van Loo, Charles Swanton, Nicholas McGranahan, Roland F Schwarz
Published 2023-10-01
Article -
11
Publisher Correction: Genomic instability in mutant p53 cancer cells upon entotic engulfment by Hannah L. Mackay, David Moore, Callum Hall, Nicolai J. Birkbak, Mariam Jamal-Hanjani, Saadia A. Karim, Vinaya M. Phatak, Lucia Piñon, Jennifer P. Morton, Charles Swanton, John Le Quesne, Patricia A. J. Muller
Published 2018-08-01
Article -
12
Prospective analysis of 895 patients on a UK Genomics Review Board by David Allan Moore, Marina Kushnir, Gabriel Mak, Helen Winter, Teresa Curiel, Mark Voskoboynik, Michele Moschetta, Nataliya Rozumna-Martynyuk, Kevin Balbi, Philip Bennett, Martin Forster, Anjana Kulkarni, Debra Haynes, Charles Swanton, Hendrik-Tobias Arkenau
Published 2019-04-01
Article -
13
Quantifying the impact of immunotherapy on RNA dynamics in cancer by Yin Wu, Charles Swanton, Mihaela Angelova, Crispin Hiley, Marleen Kok, Nicolai Birkbak, Ieva Usaite, Dhruva Biswas, Krijn Dijkstra, Thomas BK Watkins, Oriol Pich, Clare Puttick, Krupa Thakkar, Simone Zaccaria, Kevin Litchfield, Nnennaya Kanu
Published 2023-11-01
Article -
14
MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution by Tom L. Kaufmann, Marina Petkovic, Thomas B. K. Watkins, Emma C. Colliver, Sofya Laskina, Nisha Thapa, Darlan C. Minussi, Nicholas Navin, Charles Swanton, Peter Van Loo, Kerstin Haase, Maxime Tarabichi, Roland F. Schwarz
Published 2022-11-01
Article -
15
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study by Andjelija Zivanovic Bujak, Chen-Fang Weng, Maria João Silva, Miriam Yeung, Louisa Lo, Sarah Ftouni, Cassandra Litchfield, Yi-An Ko, Keilly Kuykhoven, Courtney Van Geelen, Sushma Chandrashekar, Mark A. Dawson, Sherene Loi, Stephen Q. Wong, Sarah-Jane Dawson, Charles Swanton
Published 2020-10-01
Article -
16
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry by Febe van Maldegem, Karishma Valand, Megan Cole, Harshil Patel, Mihaela Angelova, Sareena Rana, Emma Colliver, Katey Enfield, Nourdine Bah, Gavin Kelly, Victoria Siu Kwan Tsang, Edurne Mugarza, Christopher Moore, Philip Hobson, Dina Levi, Miriam Molina-Arcas, Charles Swanton, Julian Downward
Published 2021-10-01
Article -
17
Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis by Cristina Morales Torres, Mary Y. Wu, Sebastijan Hobor, Elanor N. Wainwright, Matthew J. Martin, Harshil Patel, William Grey, Eva Grönroos, Steven Howell, Joana Carvalho, Ambrosius P. Snijders, Michael Bustin, Dominique Bonnet, Paul D. Smith, Charles Swanton, Michael Howell, Paola Scaffidi
Published 2020-04-01
Article -
18
Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE". by Peter Savas, Zhi Ling Teo, Christophe Lefevre, Christoffer Flensburg, Franco Caramia, Kathryn Alsop, Mariam Mansour, Prudence A Francis, Heather A Thorne, Maria Joao Silva, Nnennaya Kanu, Michelle Dietzen, Andrew Rowan, Maik Kschischo, Stephen Fox, David D Bowtell, Sarah-Jane Dawson, Terence P Speed, Charles Swanton, Sherene Loi
Published 2017-04-01
Article -
19
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity by Kevin Litchfield, James L. Reading, Emilia L. Lim, Hang Xu, Po Liu, Maise Al-Bakir, Yien Ning Sophia Wong, Andrew Rowan, Samuel A. Funt, Taha Merghoub, David Perkins, Martin Lauss, Inge Marie Svane, Göran Jönsson, Javier Herrero, James Larkin, Sergio A. Quezada, Matthew D. Hellmann, Samra Turajlic, Charles Swanton
Published 2020-07-01
Article -
20
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones by A. M. Mahedi Hasan, Paolo Cremaschi, Daniel Wetterskog, Anuradha Jayaram, Stephen Q. Wong, Scott Williams, Anupama Pasam, Anna Trigos, Blanca Trujillo, Emily Grist, Stefanie Friedrich, Osvaldas Vainauskas, Marina Parry, Mazlina Ismail, Wout Devlies, Anna Wingate, Mark Linch, Cristina Naceur-Lombardelli, PEACE consortium, Charles Swanton, Mariam Jamal-Hanjani, Stefano Lise, Shahneen Sandhu, Gerhardt Attard
Published 2023-08-01
Article